Lower-than-usual levels of the protein SIRT1 are evident in the blood of people with Parkinson’s…
Steve Bryson, PhD
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new vaccines and medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson, PhD
Mutations in the PARK7 gene, known to cause early onset Parkinson’s disease, result in low…
Neupro patches placed on the shin caused significantly less skin irritation and itching in people with…
In a real-world clinical setting, Neupro Patches (rotigotine) eased the clinical signs and…
The number of people with early-stage Parkinson’s disease who reported sleep disturbances increased…
The natural compound kaempferol — which acts as a potent antioxidant — can reduce the physical…
Working-age adults with Parkinson’s disease who received deep brain stimulation (DBS) showed…
Researchers have developed a highly sensitive but low-cost method to detect dopamine, which may help in the early…
A direct causal link was found between two major underlying features of Parkinson’s disease — mitochondrial defects…
With a single treatment, scientists were able to transform brain cells into functioning neurons that restored dopamine —…